Hypertension Research
Online ISSN : 1348-4214
Print ISSN : 0916-9636
ISSN-L : 0916-9636
Effects of Chronic Treatment with Calcium Channel Blockers or Angiotensin Converting Enzyme Inhibitors on Renal Function in Streptozotocin-Treated Hypertensive Diabetic Rats
Kazunori YoshidaMinoru YasujimaMasahiro KohzukiMasayuki KanazawaKeishi Abe
Author information
JOURNAL FREE ACCESS

1994 Volume 17 Issue 1 Pages 35-41

Details
Abstract

To assess renal benefits of calcium channel blockers (CCBs) and angiotensin converting enzyme inhibitors (ACEIs) in diabetic rats with renal impairment, we administered CCBs, nifedipine (NIF) and benidipine (BEN), or ACEIs, captopril (CAP) and trandolapril (TRA), for 12 weeks, and studied changes in systolic blood pressure (SBP) and urinary protein excretion (UP) in uninephrectomized spontaneously hypertensive rats and Wistar-Kyoto rats with diabetes mellitus induces by streptozotocin administration (WKY-STZ and SHR-STZ). In WKY-STZ, both the CCBs and the ACEIs decreased SBP and UP similarly. UP of SHR-STZ was more than that of WKY-STZ. Both the CCBs and the ACEIs attenuated the development of hypertension in SHR-STZ similarly. However, UP in the ACEIs group was significantly less than that of the control (no treatment), whereas UP in the CCBs group was not significantly less than that of the control. These results indicate that hypertension may accelerate diabetic nephropathy. They also indicate that reduction of systemic blood pressure does not always lessen the renal injury in this model of rats. ACEIs were more potent in reducing proteinuria than CCBs in this diabetic model in rats partly because ACEIs may preferentially reduce the intraglomerular capillary pressure. (Hypertens Res 1994; 17: 35-41)

Content from these authors
© The Japanese Society of Hypertension
Previous article Next article
feedback
Top